Inflammasome Priming in Sterile Inflammatory Disease.

[1]  S. Ryter,et al.  UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis , 2023, The Journal of clinical investigation.

[2]  M. McDermott,et al.  Faculty Opinions recommendation of Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[3]  Xiangmei Zhou,et al.  The role of mitochondria in NLRP3 inflammasome activation. , 2018, Molecular immunology.

[4]  G. Núñez,et al.  Mechanism and Regulation of NLRP3 Inflammasome Activation. , 2016, Trends in biochemical sciences.

[5]  Sky W. Brubaker,et al.  Complement pathway amplifies caspase-11–dependent cell death and endotoxin-induced sepsis severity , 2016, The Journal of experimental medicine.

[6]  Si Ming Man,et al.  IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes , 2016, Cell.

[7]  V. Hornung,et al.  Aging-Associated TNF Production Primes Inflammasome Activation and NLRP3-Related Metabolic Disturbances , 2016, The Journal of Immunology.

[8]  Xuebin Qin,et al.  Target deletion of complement component 9 attenuates antibody-mediated hemolysis and lipopolysaccharide (LPS)-induced acute shock in mice , 2016, Scientific Reports.

[9]  Yajing Wang,et al.  Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation. , 2016, Biochemical pharmacology.

[10]  Maxim N. Artyomov,et al.  Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. , 2016, Cell metabolism.

[11]  S. Maier,et al.  The redox state of the alarmin HMGB1 is a pivotal factor in neuroinflammatory and microglial priming: A role for the NLRP3 inflammasome , 2016, Brain, Behavior, and Immunity.

[12]  T. Kanneganti,et al.  Autoinflammatory Skin Disorders: The Inflammasomme in Focus. , 2016, Trends in molecular medicine.

[13]  P. Ward,et al.  Bidirectional Crosstalk between C5a Receptors and the NLRP3 Inflammasome in Macrophages and Monocytes , 2016, Mediators of inflammation.

[14]  James R. Springstead,et al.  An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells , 2016, Science.

[15]  B. Morgan,et al.  The membrane attack complex as an inflammatory trigger. , 2016, Immunobiology.

[16]  Alessandra Pedrocchi,et al.  Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid , 2016, Mediators of inflammation.

[17]  E. Latz,et al.  Crystal Formation in Inflammation. , 2016, Annual review of immunology.

[18]  F. Sutterwala,et al.  Complement-mediated ‘bystander’ damage initiates host NLRP3 inflammasome activation , 2016, Journal of Cell Science.

[19]  D. Choubey,et al.  Hypoxia primes human normal prostate epithelial cells and cancer cell lines for the NLRP3 and AIM2 inflammasome activation , 2016, Oncotarget.

[20]  Vikas Gupta,et al.  MicroRNA therapeutics: Discovering novel targets and developing specific therapy , 2016, Perspectives in clinical research.

[21]  Charles C. Kim,et al.  Saturated Fatty Acids Engage an IRE1α-Dependent Pathway to Activate the NLRP3 Inflammasome in Myeloid Cells. , 2016, Cell reports.

[22]  Jelena S. Bezbradica,et al.  Sterile signals generate weaker and delayed macrophage NLRP3 inflammasome responses relative to microbial signals , 2016, Cellular & Molecular Immunology.

[23]  J. Ehses,et al.  Differential Activation of Innate Immune Pathways by Distinct Islet Amyloid Polypeptide (IAPP) Aggregates* , 2016, The Journal of Biological Chemistry.

[24]  E. Pearce,et al.  Immunometabolism governs dendritic cell and macrophage function , 2016, The Journal of experimental medicine.

[25]  Soonkyu Chung,et al.  Suppression of NLRP3 inflammasome by γ-tocotrienol ameliorates type 2 diabetes[S] , 2016, Journal of Lipid Research.

[26]  J. Yewdell,et al.  Post-transcriptional control of NLRP3 inflammasome activation in colonic macrophages , 2015, Mucosal Immunology.

[27]  Inhwa Hwang,et al.  Histone deacetylase 6 negatively regulates NLRP3 inflammasome activation. , 2015, Biochemical and biophysical research communications.

[28]  F. Holz,et al.  Complement Component C5a Primes Retinal Pigment Epithelial Cells for Inflammasome Activation by Lipofuscin-mediated Photooxidative Damage* , 2015, The Journal of Biological Chemistry.

[29]  D. Su,et al.  NLRP3 inflammasome and its inhibitors: a review , 2015, Front. Pharmacol..

[30]  K. Schroder,et al.  NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5 , 2015, European journal of immunology.

[31]  M. Lamkanfi,et al.  Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation , 2015, Scientific Reports.

[32]  Denise N. Bronner,et al.  Endoplasmic Reticulum Stress Activates the Inflammasome via NLRP3- and Caspase-2-Driven Mitochondrial Damage. , 2015, Immunity.

[33]  R. Deshaies.  Protein degradation: Prime time for PROTACs. , 2015, Nature chemical biology.

[34]  J. Gugenheim,et al.  ER stress induces NLRP3 inflammasome activation and hepatocyte death , 2015, Cell Death and Disease.

[35]  E. Lien,et al.  Early Upregulation of NLRP3 in the Brain of Neonatal Mice Exposed to Hypoxia-Ischemia: No Early Neuroprotective Effects of NLRP3 Deficiency , 2015, Neonatology.

[36]  E. Gratton,et al.  LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling , 2015, eLife.

[37]  S. Ryter,et al.  mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation. , 2015, Cell reports.

[38]  M. Idzko,et al.  MicroRNA-155-deficient dendritic cells cause less severe GVHD through reduced migration and defective inflammasome activation. , 2015, Blood.

[39]  Haitao Guo,et al.  Inflammasomes: mechanism of action, role in disease, and therapeutics , 2015, Nature Medicine.

[40]  Jian-Mei Li,et al.  Pterostilbene and allopurinol reduce fructose-induced podocyte oxidative stress and inflammation via microRNA-377. , 2015, Free radical biology & medicine.

[41]  J. Kuemmerle-Deschner.  CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease , 2015, Seminars in Immunopathology.

[42]  F. Azuaje,et al.  Permanent Culture of Macrophages at Physiological Oxygen Attenuates the Antioxidant and Immunomodulatory Properties of Dimethyl Fumarate , 2015, Journal of cellular physiology.

[43]  J. Qu,et al.  Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients. , 2015, Experimental eye research.

[44]  D. Monack,et al.  Bacterial recognition pathways that lead to inflammasome activation , 2015, Immunological reviews.

[45]  I. Spasojević,et al.  A Comparative Analysis of Multiple Sclerosis–Relevant Anti-Inflammatory Properties of Ethyl Pyruvate and Dimethyl Fumarate , 2015, The Journal of Immunology.

[46]  Junying Yuan.  Faculty Opinions recommendation of Caspase-8 regulates TNF-α-induced epithelial necroptosis and terminal ileitis. , 2015 .

[47]  Sarah L. Doyle,et al.  Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives , 2015, Journal of inflammation research.

[48]  S. Akira,et al.  Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation , 2014, Proceedings of the National Academy of Sciences.

[49]  T. Reimer,et al.  Complement C5a potentiates uric acid crystal‐induced IL‐1β production , 2014, European journal of immunology.

[50]  P. Libby,et al.  Moderate Hypoxia Potentiates Interleukin-1&bgr; Production in Activated Human Macrophages , 2014, Circulation research.

[51]  M. Lamkanfi,et al.  Reactive Oxygen Species Regulate Caspase-11 Expression and Activation of the Non-canonical NLRP3 Inflammasome during Enteric Pathogen Infection , 2014, PLoS pathogens.

[52]  P. Li,et al.  Inflammatory caspases are innate immune receptors for intracellular LPS , 2014, Nature.

[53]  Zhonghan Li,et al.  Therapeutic targeting of microRNAs: current status and future challenges , 2014, Nature Reviews Drug Discovery.

[54]  A. Wree,et al.  NLRP3 inflammasome activation is required for fibrosis development in NAFLD , 2014, Journal of Molecular Medicine.

[55]  E. Alnemri,et al.  Inflammasome Priming by Lipopolysaccharide Is Dependent upon ERK Signaling and Proteasome Function , 2014, The Journal of Immunology.

[56]  J. Ehses,et al.  Resident Macrophages Mediate Islet Amyloid Polypeptide–Induced Islet IL-1β Production and β-Cell Dysfunction , 2014, Diabetes.

[57]  G. van Loo,et al.  Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis , 2014, Nature.

[58]  John D Lambris,et al.  Cholesterol Crystals Induce Complement-Dependent Inflammasome Activation and Cytokine Release , 2014, The Journal of Immunology.

[59]  D. Green,et al.  FADD and Caspase-8 Mediate Priming and Activation of the Canonical and Noncanonical Nlrp3 Inflammasomes , 2014, The Journal of Immunology.

[60]  J. Köhl,et al.  C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. , 2013, Blood.

[61]  J. Walkowiak,et al.  Butyric acid in functional constipation , 2013, Przeglad gastroenterologiczny.

[62]  E. Alnemri,et al.  Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome , 2013, The Journal of Immunology.

[63]  T. Ichinohe,et al.  Mitochondrial protein mitofusin 2 is required for NLRP3 inflammasome activation after RNA virus infection , 2013, Proceedings of the National Academy of Sciences.

[64]  R. Lockey,et al.  MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2. , 2013, Biochemical and biophysical research communications.

[65]  D. Powell,et al.  Cytoplasmic LPS Activates Caspase-11: Implications in TLR4-Independent Endotoxic Shock , 2013, Science.

[66]  M. T. Wong,et al.  Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4 , 2013, Science.

[67]  F. Sutterwala,et al.  Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. , 2013, Immunity.

[68]  J. Simard,et al.  S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-κB1 , 2013, PloS one.

[69]  T. Hughes,et al.  Cutting Edge: The NLRP3 Inflammasome Links Complement-Mediated Inflammation and IL-1β Release , 2013, The Journal of Immunology.

[70]  Eun-Hee Kim,et al.  Cobalt Chloride-induced Hypoxia Ameliorates NLRP3-Mediated Caspase-1 Activation in Mixed Glial Cultures , 2013, Immune network.

[71]  Traci L. Marin,et al.  Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility , 2013, Circulation.

[72]  T. Hughes,et al.  The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation , 2013, Journal of Cell Science.

[73]  H. Kwon,et al.  Adipokines Mediate Inflammation and Insulin Resistance , 2013, Front. Endocrinol..

[74]  Nan Li,et al.  Immune Responsive Gene 1 (IRG1) Promotes Endotoxin Tolerance by Increasing A20 Expression in Macrophages through Reactive Oxygen Species* , 2013, The Journal of Biological Chemistry.

[75]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[76]  Shuzhen Chen,et al.  Negative regulation of NLRP3 inflammasome signaling , 2013, Protein & Cell.

[77]  Daniel E. Zak,et al.  Caspase-11 Protects Against Bacteria That Escape the Vacuole , 2013, Science.

[78]  M. Haneklaus,et al.  Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments. , 2013, Current opinion in immunology.

[79]  M. Brucale,et al.  Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies , 2013, PloS one.

[80]  Junying Yuan,et al.  Deubiquitination of NLRP3 by BRCC3 critically regulates inflammasome activity. , 2013, Molecular cell.

[81]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[82]  M. Shong,et al.  Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes , 2012, Diabetes.

[83]  G. López-Castejón,et al.  Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1β Secretion via Assembly of the Inflammasome , 2012, The Journal of Biological Chemistry.

[84]  Anna K Rieger,et al.  NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223 , 2012, The Journal of Immunology.

[85]  E. Alnemri,et al.  Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation* , 2012, The Journal of Biological Chemistry.

[86]  G. Szabo,et al.  Inflammasomes in liver diseases. , 2012, Journal of hepatology.

[87]  K. Fransén,et al.  Role of NLRP3 and CARD8 in the regulation of TNF-α induced IL-1β release in vascular smooth muscle cells. , 2012, International journal of molecular medicine.

[88]  M. Lamkanfi,et al.  Toll or Interleukin-1 Receptor (TIR) Domain-containing Adaptor Inducing Interferon-β (TRIF)-mediated Caspase-11 Protease Production Integrates Toll-like Receptor 4 (TLR4) Protein- and Nlrp3 Inflammasome-mediated Host Defense against Enteropathogens* , 2012, The Journal of Biological Chemistry.

[89]  Christine E. Becker,et al.  TRIF Licenses Caspase-11-Dependent NLRP3 Inflammasome Activation by Gram-Negative Bacteria , 2012, Cell.

[90]  H. Roche,et al.  Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. , 2012, Molecular nutrition & food research.

[91]  G. Núñez,et al.  Critical role for mast cells in interleukin-1β-driven skin inflammation associated with an activating mutation in the nlrp3 protein. , 2012, Immunity.

[92]  Kamila Belhocine,et al.  Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1 , 2012, Nature.

[93]  Yuhong Yang,et al.  Dimethyl Fumarate Inhibits Dendritic Cell Maturation via Nuclear Factor κB (NF-κB) and Extracellular Signal-regulated Kinase 1 and 2 (ERK1/2) and Mitogen Stress-activated Kinase 1 (MSK1) Signaling* , 2012, The Journal of Biological Chemistry.

[94]  Moshe Arditi,et al.  Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. , 2012, Immunity.

[95]  G. Núñez,et al.  Sensing and reacting to microbes through the inflammasomes , 2012, Nature Immunology.

[96]  Richard A. Flavell,et al.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity , 2012, Nature.

[97]  Helmut Neumann,et al.  Caspase-8 regulates TNF-alpha induced epithelial necroptosis and terminal ileitis , 2011, Nature.

[98]  L. Joosten,et al.  Inflammasome is a central player in the induction of obesity and insulin resistance , 2011, Proceedings of the National Academy of Sciences.

[99]  Jamaal A Rehman,et al.  TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease , 2011, Journal of Neuroinflammation.

[100]  Anna K Rieger,et al.  Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome , 2011, The Journal of Immunology.

[101]  Denis Gris,et al.  Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling , 2011, Nature Immunology.

[102]  S. Masters,et al.  Disease-associated amyloid and misfolded protein aggregates activate the inflammasome. , 2011, Trends in molecular medicine.

[103]  Haitao Wen,et al.  The inflammasome NLRs in immunity, inflammation, and associated diseases. , 2011, Annual review of immunology.

[104]  S. Ryter,et al.  Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. , 2011, Nature immunology.

[105]  T. Roger,et al.  Basic Calcium Phosphate Crystals Induce Monocyte/Macrophage IL-1β Secretion through the NLRP3 Inflammasome In Vitro , 2011, The Journal of Immunology.

[106]  E. Ravussin,et al.  The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.

[107]  Christine E. Becker,et al.  Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes , 2010, Nature Immunology.

[108]  Jennifer R. Clark,et al.  Complement-mediated regulation of the interleukin 17A axis is a central genetic determinant of the severity of experimental allergic asthma , 2010, Nature Immunology.

[109]  Egil Lien,et al.  NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals , 2010, Nature.

[110]  F. Meissner,et al.  Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis , 2010, Proceedings of the National Academy of Sciences.

[111]  M. Chatzopoulou,et al.  RAGE: a multi-ligand receptor unveiling novel insights in health and disease. , 2010, Current medicinal chemistry.

[112]  M. Wills-Karp,et al.  Complement-mediated Regulation Of The IL-17A Axis Is A Central Genetic Determinant Of The Severity Of Experimental Allergic Asthma , 2010, ATS 2010.

[113]  L. Orci,et al.  Lipid homeostasis, lipotoxicity and the metabolic syndrome. , 2010, Biochimica et biophysica acta.

[114]  J. Tschopp,et al.  NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? , 2010, Nature Reviews Immunology.

[115]  K. Moore,et al.  NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease , 2010, Nature.

[116]  J. Tschopp,et al.  Thioredoxin-interacting protein links oxidative stress to inflammasome activation , 2010, Nature Immunology.

[117]  R. Vance.  Inflammasome activation: how macrophages watch what they eat. , 2010, Cell host & microbe.

[118]  F. Sutterwala,et al.  Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome , 2009, Proceedings of the National Academy of Sciences.

[119]  C. Bryant,et al.  Molecular mechanisms involved in inflammasome activation. , 2009, Trends in cell biology.

[120]  G. Núñez,et al.  Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1 , 2009, The Journal of Immunology.

[121]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[122]  K. Shin,et al.  Suppression of caspase-11 expression by histone deacetylase inhibitors. , 2009, Biochemical and biophysical research communications.

[123]  F. Martinon.  Detection of immune danger signals by NALP3 , 2008, Journal of leukocyte biology.

[124]  D. Jacobs,et al.  The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2007, Atherosclerosis.

[125]  S. Weisnagel,et al.  Circulating oxidized LDL is associated with parameters of the metabolic syndrome in postmenopausal women. , 2007, Atherosclerosis.

[126]  C. Murga,et al.  The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. , 2007, Biochimica et biophysica acta.

[127]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[128]  J. Capeau,et al.  Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes , 2006, Diabetologia.

[129]  S. Frede,et al.  Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB. , 2006, The Biochemical journal.

[130]  N. Bergeron,et al.  Circulating levels of oxidative stress markers and endothelial adhesion molecules in men with abdominal obesity. , 2005, The Journal of clinical endocrinology and metabolism.

[131]  A. la Sala,et al.  Gi-Protein-Dependent Inhibition of IL-12 Production Is Mediated by Activation of the Phosphatidylinositol 3-Kinase-Protein 3 Kinase B/Akt Pathway and JNK , 2005, The Journal of Immunology.

[132]  C. Schneider,et al.  Ceramide triggers an NF-κB-dependent survival pathway through calpain , 2005, Cell Death and Differentiation.

[133]  S. Rubin,et al.  The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort. , 2004, Diabetes.

[134]  F. Martinon,et al.  NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. , 2004, Immunity.

[135]  Y. Itoyama,et al.  Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice. , 2003, Biochemical and biophysical research communications.

[136]  R. C. Ho,et al.  Whole-body insulin sensitivity, low-density lipoprotein (LDL) particle size, and oxidized LDL in overweight, nondiabetic men. , 2002, Metabolism: clinical and experimental.

[137]  Peter Schotte,et al.  Caspase-11 Gene Expression in Response to Lipopolysaccharide and Interferon-γ Requires Nuclear Factor-κB and Signal Transducer and Activator of Transcription (STAT) 1* , 2002, The Journal of Biological Chemistry.

[138]  B. Jaber,et al.  C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. , 2002, Kidney international.

[139]  田中 弘之,et al.  軟骨無形成症発症機序におけるSignal Transducer and Activator of Transcription (Stat)1の機能的役割 , 2001 .

[140]  F. Van de Werf,et al.  Circulating Oxidized LDL Is a Useful Marker for Identifying Patients With Coronary Artery Disease , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[141]  F. Wright,et al.  Identification of a locus on chromosome 1q44 for familial cold urticaria. , 2000, American journal of human genetics.

[142]  G. Fantuzzi,et al.  Gene expression, synthesis, and secretion of interleukin 18 and interleukin 1beta are differentially regulated in human blood mononuclear cells and mouse spleen cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[143]  Huiping Jiang,et al.  Pertussis Toxin-sensitive Activation of Phospholipase C by the C5a and fMet-Leu-Phe Receptors* , 1996, The Journal of Biological Chemistry.

[144]  G. Johnson,et al.  Mapping of the C5a receptor signal transduction network in human neutrophils. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[145]  M. Brown,et al.  SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[146]  A. Admon,et al.  SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene , 1993, Cell.

[147]  J. Hiscott,et al.  Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.

[148]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[149]  R. Egan,et al.  Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides. , 1990, Journal of immunology.

[150]  M. Fishbein,et al.  Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.

[151]  B. Morgan.  Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. , 1989, The Biochemical journal.

[152]  J. Cavaillon,et al.  C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. , 1987, Journal of immunology.

[153]  H. Müller-Eberhard.  The membrane attack complex of complement. , 1986, Annual review of immunology.

[154]  J. Tanti,et al.  Interleukin-1 (cid:1) -Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression , 2022 .